Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Macrocyclic lactone.
FLT3, c-Kit, PDGFR inhibitor.
NLRP3 and caspase-1 inhibitor.
Ornithine decarboxylase inhibitor.
JAK2 inhibitor.
Peptide, substance P analog; NK agonist.
Synthetic cafestol derivative.
Steroidogenesis inhibitor
Pt-based DNA cross-linker.
Iridoid glycoside found in Gardinia jasminoides...
Benzimidazole; microtubule polymerization inhib...
Thienylbutyl ITC analog.
Taxane found in species of Taxus; potential mic...
Induces activation of Nrf2; inhibits apoptosis ...
Alkaloid found in species of Loranthus, Calia, ...
p53 inhibitor
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
β1-adrenergic agonist, β2- and α1-adrenergic...
Used for in vitro fertilization; FIASMA, SERM.<...
Endogenous peptide hormone, glugagon fragment; ...